Epizyme As A Strategic Acquisition For Epigenetic Therapies [Seeking Alpha]
Epizyme, Inc. (EPZM)
Last epizyme, inc. earnings: 2/24 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
epizyme.com
Company Research
Source: Seeking Alpha
Epizyme As A Strategic Acquisition For Epigenetic Therapies Summary Epigenetics is a new therapeutic area with strategic implications. Epizyme's stock price has recovered following announced timeline for NDAs. Short-term, Tazemetostat approval (or not) is the main stock price driver. Platform development is more important longer term. Epizyme ( EPZM I believe Epizyme is a strategic company for investors to acquire. Epigenetic therapies are likely to be major revenue and profit drivers in the coming century. Why epigenetic therapies are strategic Phenotypic traits There are multiple mechanisms in cancer epigenetics Epizyme's research and development efforts are focused on histone inhibition, which in turn can effect methylation. Tazemetostat status There are several trials underway for tazemetostat, including as a single agent therapy for epithelioid sarcoma, follicular lymphoma, and mesothelioma. Combination trials with R-CHOP chemotherapy and Tecentriq (atezolizumab) are also underwa
Show less
Read more
Impact Snapshot
Event Time:
EPZM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EPZM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EPZM alerts
High impacting Epizyme, Inc. news events
Weekly update
A roundup of the hottest topics